In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
08/06/2026-15:59 08/06/2026-16:05 מחשבים וטכנולוגיה Forbes Innovation דיווח
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic p
